Andrew E. Budson, M.D. is Chief of Cognitive & Behavioral Neurology, Associate Chief of Staff for Education, and Director of the Center for Translational Cognitive Neuroscience at the Veterans Affairs (VA) Boston Healthcare System, Associate Director for Research at the Boston University Alzheimer’s Disease Center, Professor of Neurology at Boston University School of Medicine, and Lecturer in Neurology at Harvard Medical School. He is also the Medical Director of the Boston Center for Memory, located in Newton, Massachusetts. His training included graduating cum laude from Harvard Medical School, being chief resident of the Harvard-Longwood Neurology Residency Program, pursuing a fellowship in dementia at Brigham and Women’s Hospital, and studying memory as a post-doctoral fellow in experimental psychology and cognitive neuroscience at Harvard University. Dr. Budson has had government research funding since 1998, receiving a National Research Service Award and a Career Development Award in addition to a Research Project (R01) grant. He has given over 425 local, national, and international grand rounds and other academic talks. He has published over 100 papers, reviews, and book chapters and is a reviewer for more than 40 journals. He has co-authored or edited five books, including Memory Loss, Alzheimer’s Disease, and Dementia: A Practical Guide for Clinicians, the second edition of which has been translated into Spanish, Portuguese, and Japanese. He was awarded the Norman Geschwind Prize in Behavioral Neurology in 2008 and the Research Award in Geriatric Neurology in 2009, both from the American Academy of Neurology. His current research uses the techniques of experimental psychology and cognitive neuroscience to understand memory in patients with Alzheimer’s disease. In his memory disorders clinic at the VA Boston Healthcare System he treats patients while teaching fellows, residents, and medical students. He also sees patients in Newton at the Boston Center for Memory.
- Associate Director for Research, Alzheimer's Disease Center, Boston University School of Medicine
- Professor, Pathology & Laboratory Medicine, Boston University School of Medicine
- Consultant Neurologist, Division of Cognitive & Behavioral Neurology, Neurology, Brigham and Women's Hospital
- Associate Chief of Staff for Education, VA Boston Healthcare System
- Director, Center for Translational Cognitive Neuroscience, VA Boston Healthcare System
- Director, Cognitive Neuroscience Research, Alzheimer’s Disease Center, Boston University School of Medicine
- Lecturer in Neurology, Neurology, Harvard Medical School
- Physician, Geriatric Research Education Clinical Center & Neurology Services, VA Boston Healthcare System
- VA Boston Healthcare System
- Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Graduate Medical Sciences
- Harvard Medical School, MD
- Harverford College, BA
- Published on 12/2/2021
Frank B, Ally M, Brekke B, Zetterberg H, Blennow K, Sugarman MA, Ashton NJ, Karikari TK, Tripodis Y, Martin B, Palmisano JN, Steinberg EG, Simkina I, Turk KW, Budson AE, O'Connor MK, Au R, Goldstein LE, Jun GR, Kowall NW, Stein TD, McKee AC, Killiany R, Qiu WQ, Stern RA, Mez J, Alosco ML. Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau. Alzheimers Dement. 2021 Dec 02. PMID: 34854549.
- Published on 8/1/2021
Vives-Rodriguez A, Turk KW, Vassey EA, Singhal T, Cho CH, Budson AE. Reversible Amnestic Cognitive Impairment in a Patient With Brain Sagging Syndrome. Neurol Clin Pract. 2021 Aug; 11(4):e551-e554. PMID: 34484956.
- Published on 7/15/2021
Tao Q, Alvin Ang TF, Akhter-Khan SC, Itchapurapu IS, Killiany R, Zhang X, Budson AE, Turk KW, Goldstein L, Mez J, Alosco ML, Qiu WQ. Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous Apolipoprotein E ?4 Carriers. Neurology. 2021 Jul 15. PMID: 34266923.
- Published on 6/14/2021
Turk KW, Marin A, Schiloski KA, Vives-Rodriguez AL, Uppal P, Suh C, Dwyer B, Palumbo R, Budson AE. Head Injury Exposure in Veterans Presenting to Memory Disorders Clinic: An Observational Study of Clinical Characteristics and Relationship of Event-Related Potentials and Imaging Markers. Front Neurol. 2021; 12:626767. PMID: 34194379.
- Published on 2/3/2021
Zhang W, Budson AE, Gutchess A. Effect of self-imagination on memory for older adults and aMCI patients. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2021 Feb 03; 1-16. PMID: 33530871.
- Published on 1/20/2021
Walker JM, Richardson TE, Farrell K, Iida MA, Foong C, Shang P, Attems J, Ayalon G, Beach TG, Bigio EH, Budson A, Cairns NJ, Corrada M, Cortes E, Dickson DW, Fischer P, Flanagan ME, Franklin E, Gearing M, Glass J, Hansen LA, Haroutunian V, Hof PR, Honig L, Kawas C, Keene CD, Kofler J, Kovacs GG, Lee EB, Lutz MI, Mao Q, Masliah E, McKee AC, McMillan CT, Mesulam MM, Murray M, Nelson PT, Perrin R, Pham T, Poon W, Purohit DP, Rissman RA, Sakai K, Sano M, Schneider JA, Stein TD, Teich AF, Trojanowski JQ, Troncoso JC, Vonsattel JP, Weintraub S, Wolk DA, Woltjer RL, Yamada M, Yu L, White CL, Crary JF. Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. J Neuropathol Exp Neurol. 2021 01 20; 80(2):102-111. PMID: 33367843.
- Published on 1/1/2021
Indorewalla KK, O'Connor MK, Budson AE, Guess DiTerlizzi C, Jackson J. Modifiable Barriers for Recruitment and Retention of Older Adults Participants from Underrepresented Minorities in Alzheimer's Disease Research. J Alzheimers Dis. 2021; 80(3):927-940. PMID: 33612540.
- Published on 8/10/2020
Malone C, Turk KW, Palumbo R, Budson AE. The Effectiveness of Item-Specific Encoding and Conservative Responding to Reduce False Memories in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia. J Int Neuropsychol Soc. 2021 03; 27(3):227-238. PMID: 32772946.
- Published on 6/17/2020
Topor DR, Budson AE. Twelve tips to present an effective webinar. Med Teach. 2020 11; 42(11):1216-1220. PMID: 33096974.
- Published on 5/29/2020
Sugarman MA, Zetterberg H, Blennow K, Tripodis Y, McKee AC, Stein TD, Martin B, Palmisano JN, Steinberg EG, Simkin I, Budson AE, Killiany R, O'Connor MK, Au R, Qiu WWQ, Goldstein LE, Kowall NW, Mez J, Stern RA, Alosco ML. A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease. Neurobiol Aging. 2020 10; 94:60-70. PMID: 32585491.
View 125 more publications: View full profile at BUMC